Sector: Pharmaceuticals & Biotechnology

Small Cap

Venmax Drugs Share Price

Venmax Drugs & Pharmaceuticals Ltd.

₹24.86

1.68(7.25%)

Trade Now

27th May 2026 | 2:24 PM

NSE :

Open Free Demat Account

Venmax Drugs Performance

Price Movement

N/A

₹23.00

₹26.99

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹26.99

Low₹23.00

Open at₹26.99

Prev Close₹23.18

Volumes3.02 K

Avg Price₹23.95

Lower Circuit₹19.89

Upper Circuit₹29.83

Historical Performance

3M High₹30.00

3M Low₹20.80

1 Yr High₹36.96

1 Yr Low₹19.01

3 Yr High₹36.96

3 Yr Low₹6.27

5 Yr High₹36.96

5 Yr Low₹6.27

Venmax Drugs Fundamentals

Market Cap

Low in industry

21.80 Cr.

PE Ratio (TTM)

High in industry

108.60

Dividend Yield

Net Profit TTM

2100.0% incr over last year

0.20

Net Profit Growth

2100.0% incr over last year

0.20

PEG Ratio

Below industry Median

0.10

ROE

860.9% incr over last year

1.75

Operating Revenue TTM

8.02

Operating Revenue Growth

890.1% incr over last year

Book Value

Below industry Median

2.30

MFI

MFI is mid-range

60.07

RSI

RSI is mid-range

43.01

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

2.30

Venmax Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	3.94	1.55	1.32	1.21	0.33
Operating Expense	3.93	1.58	1.27	1.17	0.58
Operating Profit	0.01	-0.02	0.05	0.04	-0.25
Depreciation	0	0	0	0	0
Interest	0	0	0	0	0
Tax	0	0.01	0.02	0	0
Net Profit	0.11	0.03	0.02	0.04	0.78

Venmax Drugs Technicals

Venmax Drugs & Pharmaceuticals Ltd. EMA & SMA

₹24.86

1.68 (7.25%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹23.6

Day EMA10 ₹23.8

Day EMA12 ₹23.9

Day EMA20 ₹24.2

Day EMA26 ₹24.4

Day EMA50 ₹24.8

Day EMA100 ₹25.3

Day EMA200 ₹25.1

Venmax Drugs Support and Resistance

Resistance

First Resistance₹24.43

Second Resistance₹25.67

Third Resistance₹26.39

Support

First Support₹22.47

Second Support₹21.75

Third Support₹20.51

Technical Indicators

Day RSI43.01

Day MFI60.07

Day ADX9.53

Day Commodity Channel Index-76.00

William-80.35

Day MACD-0.43

Day MACD Signal Line-0.38

Day ATR2.66

Day ROC125-21.02

Day ROC21-11.59

Venmax Drugs Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	23.1	23.1	23.1	23.1	15.1	13.8
FII	0	0	0	0	0	0
DII	0.2	0.2	0	0	0	0
Public	76.7	76.7	76.9	76.9	84.9	86.2

Venmax Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	455	1.41 K	32.11%
Week	867	1.15 K	75.23%
1 Month	1.5 K	2.01 K	75.01%
6 Month	1.52 K	1.73 K	87.84%

Venmax Drugs SWOT Analysis

Strengths16

Weakness10

Opportunity0

Threats0

Positive Breakout First Resistance ( LTP > R1)

Consistent high performing stocks over Five Years

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Increasing Revenue every Quarter for the past 8 Quarters

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Top Gainers

Venmax Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Venmax Drugs Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹46.14	₹486.75	₹218.75	₹263.90	₹42.15	₹6.46
% Change	4.98%	0.64%	-4.99%	0.00%	4.98%	0.00%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	15.60	-	22.30	37.70	-99.80	-1.50
1 Year Return		23.66			836.67	545
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 176.50

-0.84%

AMANTA

Amanta Healthcare Ltd.

₹ 132.26

-0.74%

AHCL

Anlon Healthcare Ltd.

₹ 14.29

+1.71%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 87.01

-2.22%

APL

Asston Pharmaceuticals Ltd.

₹ 73.01

+4.30%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 563.80

+1.08%

ASTONEALAB

Astonea Labs Ltd.

₹ 230.50

+0.66%

AMWILL

Amwill Health Care Ltd.

₹ 32.32

-0.19%

INNOVACAP

Innova Captab Ltd.

₹ 844.00

+0.06%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 80.00

+1.60%

SHELTER

Shelter Pharma Ltd.

₹ 30.00

-5.18%

TLL

Trident Lifeline Ltd.

₹ 248.00

-0.72%

DPL

Dipna Pharmachem Ltd.

₹ 7.75

+3.33%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.71

-1.21%

SIGACHI

Sigachi Industries Ltd.

₹ 20.57

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 821.00

-0.22%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

+0.43%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 44.00

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 544.00

-2.60%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.46

+2.22%

ZIMLAB

Zim Laboratories Ltd.

₹ 102.60

-0.77%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1305.00

-0.65%

MEDICO

Medico Remedies Ltd.

₹ 49.00

+1.51%

FAQ's on VENMAX

What is the Market Capitalization of Venmax Drugs & Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Venmax Drugs & Pharmaceuticals Ltd. is approximately ₹ 21.8 Cr.

What are the PE and PB ratios for Venmax Drugs & Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Venmax Drugs & Pharmaceuticals Ltd. is 108.6, and the Price-to-Book (PB) ratio is 2.3.

What is the 52-Week High and Low for Venmax Drugs & Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Venmax Drugs & Pharmaceuticals Ltd. shares was ₹ 36.96, and the lowest price was ₹ 19.01.

Who are the major shareholders of Venmax Drugs & Pharmaceuticals Ltd.?

Significant shareholdings in Venmax Drugs & Pharmaceuticals Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Venmax Drugs & Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Venmax Drugs & Pharmaceuticals Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy